Literature DB >> 29340742

[Wilson disease].

D Huster1.   

Abstract

Wilson disease is a rare hereditary disorder of copper metabolism. The genetic defect is caused by various mutations in the copper-transporting enzyme ATP7B, located mainly in the liver and brain. Clinical symptoms are highly variable, with any combination of hepatic and/or neurological or psychiatric manifestations. The age of onset varies from early childhood to young adults and can even be manifested in later ages. The clinical diagnosis is based on a combination of clinical, biochemical and molecular markers. Treatment using chelating agents and zinc salts is effective when started early or even better at presymptomatic stages of the disease.

Entities:  

Keywords:  Central nervous system; Chelating agents; Copper toxicity; Liver; Wilson disease protein

Mesh:

Substances:

Year:  2018        PMID: 29340742     DOI: 10.1007/s00108-017-0378-x

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  24 in total

Review 1.  Wilson disease: genetic basis of copper toxicity and natural history.

Authors:  M L Schilsky
Journal:  Semin Liver Dis       Date:  1996-02       Impact factor: 6.115

2.  Diverse functional properties of Wilson disease ATP7B variants.

Authors:  Dominik Huster; Angelika Kühne; Ashima Bhattacharjee; Lily Raines; Vanessa Jantsch; Johannes Noe; Wiebke Schirrmeister; Ines Sommerer; Osama Sabri; Frieder Berr; Joachim Mössner; Bruno Stieger; Karel Caca; Svetlana Lutsenko
Journal:  Gastroenterology       Date:  2012-01-10       Impact factor: 22.682

Review 3.  The genetics of Wilson disease.

Authors:  Irene J Chang; Si Houn Hahn
Journal:  Handb Clin Neurol       Date:  2017

4.  History of Wilson disease: a personal account.

Authors:  John M Walshe
Journal:  Handb Clin Neurol       Date:  2017

5.  Wilson's disease: clinical presentation and use of prognostic index.

Authors:  H Nazer; R J Ede; A P Mowat; R Williams
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

6.  Functional characterization of missense mutations in ATP7B: Wilson disease mutation or normal variant?

Authors:  J R Forbes; D W Cox
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

Review 7.  Wilson disease.

Authors:  Cord Langner; Helmut Denk
Journal:  Virchows Arch       Date:  2004-06-17       Impact factor: 4.064

8.  Defective cellular localization of mutant ATP7B in Wilson's disease patients and hepatoma cell lines.

Authors:  Dominik Huster; Michael Hoppert; Svetlana Lutsenko; Jan Zinke; Claudia Lehmann; Joachim Mössner; Frieder Berr; Karel Caca
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

Review 9.  Morphological and functional imaging in neurological and non-neurological Wilson's patients.

Authors:  Wieland Hermann
Journal:  Ann N Y Acad Sci       Date:  2014-02-03       Impact factor: 5.691

10.  A genetic study of Wilson's disease in the United Kingdom.

Authors:  Alison J Coffey; Miranda Durkie; Stephen Hague; Kirsten McLay; Jennifer Emmerson; Christine Lo; Stefanie Klaffke; Christopher J Joyce; Anil Dhawan; Nedim Hadzic; Giorgina Mieli-Vergani; Richard Kirk; K Elizabeth Allen; David Nicholl; Siew Wong; William Griffiths; Sarah Smithson; Nicola Giffin; Ali Taha; Sally Connolly; Godfrey T Gillett; Stuart Tanner; Jim Bonham; Basil Sharrack; Aarno Palotie; Magnus Rattray; Ann Dalton; Oliver Bandmann
Journal:  Brain       Date:  2013-03-21       Impact factor: 13.501

View more
  1 in total

1.  Beyond the "Jewish panel": the importance of offering expanded carrier screening to the Ashkenazi Jewish population.

Authors:  Shelley Dolitsky; Anjali Mitra; Shama Khan; Elena Ashkinadze; Mark V Sauer
Journal:  F S Rep       Date:  2020-08-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.